Markers of neck failure in oral cavity and oropharyngeal carcinomas treated with radiotherapy

Head and Neck

Volumn 23, Issue 2, 2001, Pages 87-93

  Fortin, André ^a   Raybaud Diogène, Hèléne ^b   Têtu, Bernard ^c   Huot, Jacques ^d   Blondeau, Lucie ^a   Landry, Jacques ^d  

^a LAVAL UNIVERSITY   (Canada)

^b Laboratory of Oral Pathologie   (France)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

GST ; HSP 27; ki 67; Neck failure; NEU; p53; Radiotherapy

Indexed keywords

HEAT SHOCK PROTEIN 27; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN P53; TUMOR MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

EID: 0035181899     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200102)23:2<87::AID-HED1003>3.0.CO;2-U     Document Type: Article

References (33)

1. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer
2. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer
3. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy
4. The management of the clinically positive neck as part of a larynx preservation approach
5. Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy
6. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: Is postradiotherapy neck dissection necessary?
7. Surgery after organ preservation therapy. Analysis of wound complications
8. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study
9. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
10. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer
11. Control by irradiation alone of nonfixed clinically positive lymph nodes from squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx
12. Radiotherapy in NO head and neck cancer patients
13. Predictors of neck node control in radically irradiated squamous cell carcinoma of the oropharynx and laryngopharynx
14. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases
15. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: Tentative multivariate modelling system to predict the radiocurability of neck nodes
16. Is reseeding from the primary a plausible cause of node failure?
17. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma
18. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy
19. erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody
20. ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors
21. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
22. Expression of HER-2/neu oncoprotein in human breast cancer: A comparison of immunohistochemical and western blot techniques
23. Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens
24. Expression of c-erbB-2 gene in human head and neck carcinoma
25. C-erbB-2 expression in squamous cell carcinoma of the head and neck
26. Markers for assessment of nodal metastasis in laryngeal carcinoma
27. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
28. Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review
29. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves
30. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: A clinicopathological and immunohistochemical study
31. Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis
32. Expression of heat shock proteins in squamous cell carcinoma of the tongue: An immunohistochemical study
33. Heat shock protein and p53 expression in head and neck squamous cell carcinoma